Literature DB >> 7499239

Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding.

C G Unson1, A M Cypess, H N Kim, P K Goldsmith, C J Carruthers, R B Merrifield, T P Sakmar.   

Abstract

Glucagon receptor mutants were characterized with the aim of elucidating minimal structural requirements for proper biosynthesis, ligand binding, and adenylyl cyclase coupling. One N-terminal deletion mutant and five truncation mutants with progressively shorter C termini were expressed in transiently transfected monkey kidney (COS-1) cells. Each truncation mutant was designed so that the truncated C-terminal tail would remain on the cytoplasmic surface of the receptor. In order to characterize the cellular location of the expressed receptor mutants, a highly specific, high affinity antipeptide antibody was prepared against the extracellular, N-terminal tail of the receptor. Immunoblot analysis and immunofluorescence microscopy showed that the presence of all seven putative transmembrane segments, but not not an intact N-terminal tail, was required for cell surface expression of the receptor. Membranes from cells expressing receptor mutants lacking a large portion of the N-terminal tail or any of the seven putative transmembrane segments failed to bind glucagon. Membranes from cells expressing the C-terminal tail truncation mutants, which retained all seven transmembrane segments, bound glucagon with affinities similar to that of the native receptor and activated cellular adenylyl cyclase in response to glucagon. These results indicate that all seven helices are necessary for the proper folding and processing of the glucagon receptor. Glycosylation is not required for the receptor to reach the cell surface, and it may not be required for ligand binding. However, the N-terminal extracellular portion of the receptor is required for ligand binding. Most of the distal C-terminal tail is not necessary for ligand binding, and the absence of the tail may increase slightly the receptor binding affinity for glucagon. The C-terminal tail is also not necessary for adenylyl cyclase coupling and therefore does not play a direct role in G protein (GS) activation by the glucagon receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499239     DOI: 10.1074/jbc.270.46.27720

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Requirement of N-glycosylation of the prostaglandin E2 receptor EP3beta for correct sorting to the plasma membrane but not for correct folding.

Authors:  U Böer; F Neuschäfer-Rube; U Möller; G P Püschel
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

2.  Evidence that the cysteine-rich domain of Drosophila Frizzled family receptors is dispensable for transducing Wingless.

Authors:  Chiann-Mun Chen; Walter Strapps; Andrew Tomlinson; Gary Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-28       Impact factor: 11.205

3.  Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.

Authors:  A Maharaj; L Zhu; F Huang; H Qiu; H Li; C Y Zhang; T Jin; Q Wang
Journal:  Diabetologia       Date:  2012-02-09       Impact factor: 10.122

4.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

5.  Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.

Authors:  S Runge; B S Wulff; K Madsen; H Bräuner-Osborne; L B Knudsen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.

Authors:  Helen C Miller; Mark Kidd; Irvin M Modlin; Patrizia Cohen; Roberto Dina; Panagiotis Drymousis; Panagiotis Vlavianos; Günter Klöppel; Andrea Frilling
Journal:  World J Gastrointest Surg       Date:  2015-04-27

7.  Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Bernard Bouscarel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

8.  Conserved extracellular cysteine residues and cytoplasmic loop-loop interplay are required for functionality of the heptahelical MLO protein.

Authors:  Candace Elliott; Judith Müller; Marco Miklis; Riyaz A Bhat; Paul Schulze-Lefert; Ralph Panstruga
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway.

Authors:  Anita Johswich; Christine Longuet; Judy Pawling; Anas Abdel Rahman; Michael Ryczko; Daniel J Drucker; James W Dennis
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

10.  Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.

Authors:  Cuiqi Zhou; Deepti Dhall; Nicholas N Nissen; Chun-Rong Chen; Run Yu
Journal:  Pancreas       Date:  2009-11       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.